73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th
Research identifies new route for tackling drug resistance in skin cancer cells

Research identifies new route for tackling drug resistance in skin cancer cells

byQueen Mary, University of LondonA drug-resistant melanoma cell that has altered its cytoskeleton. Credit: Queen Mary University of LondonResearchers have found that melanoma cells fight anti-c

Research identifies new route for tackling drug resistance in skin cancer cells

byQueen Mary, University of LondonA drug-resistant melanoma cell that has altered its cytoskeleton. Credit: Queen Mary University of LondonResearchers have found that melanoma cells fight anti-c
Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma

Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma

by Impact Journals LLCEpithelioid MPM, stage IIIB (cT4N0M0), woman, 64 years old. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28594A new research paper titled "Comparison of FDG

Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma

by Impact Journals LLCEpithelioid MPM, stage IIIB (cT4N0M0), woman, 64 years old. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28594A new research paper titled "Comparison of FDG
Most persons screened for lung cancer meet USPSTF criteria, but adherence to follow-up screening low

Most persons screened for lung cancer meet USPSTF criteria, but adherence to follow-up screening low

byAmerican College of PhysiciansCredit: Pixabay/CC0 Public DomainA cohort study of more than 1 million people has found that most persons screened for lung cancer meet U.S. Preventative Services

Most persons screened for lung cancer meet USPSTF criteria, but adherence to follow-up screening low

byAmerican College of PhysiciansCredit: Pixabay/CC0 Public DomainA cohort study of more than 1 million people has found that most persons screened for lung cancer meet U.S. Preventative Services
Huge variations between countries in time for reimbursement decisions on new cancer drugs

Huge variations between countries in time for reimbursement decisions on new cancer drugs

byEuropean Society for Medical OncologySome European countries take more than twice as long as others to reach health technology assessment (HTA) decisions to reimburse new cancer drugs followin

Huge variations between countries in time for reimbursement decisions on new cancer drugs

byEuropean Society for Medical OncologySome European countries take more than twice as long as others to reach health technology assessment (HTA) decisions to reimburse new cancer drugs followin
Variants in BRCA1/2 and MMR genes in children with cancer

Variants in BRCA1/2 and MMR genes in children with cancer

by Stefan Zorn, Medizinische Hochschule HannoverProfessor Dr. Christian Kratz, initiator of the international study that investigated the cancer risk of disease-relevant variants in BRCA1/2 and MMR ge

Variants in BRCA1/2 and MMR genes in children with cancer

by Stefan Zorn, Medizinische Hochschule HannoverProfessor Dr. Christian Kratz, initiator of the international study that investigated the cancer risk of disease-relevant variants in BRCA1/2 and MMR ge
UCLA researchers confirm mutations that predispose patients to rare kidney cancer syndrome

UCLA researchers confirm mutations that predispose patients to rare kidney cancer syndrome

Researchers at the UCLA Jonsson Comprehensive Cancer Center have confirmed that a large number of genetic variants of unknown significance are in fact verified mutations that predispose patients to a

UCLA researchers confirm mutations that predispose patients to rare kidney cancer syndrome

Researchers at the UCLA Jonsson Comprehensive Cancer Center have confirmed that a large number of genetic variants of unknown significance are in fact verified mutations that predispose patients to a
Scientists to improve cancer treatment effectiveness

Scientists to improve cancer treatment effectiveness

byNational Research Nuclear UniversityCredit: CC0 Public DomainTogether with researchers from the University of Nantes and the University of Reims Champagne-Ardenne in France, experts from the N

Scientists to improve cancer treatment effectiveness

byNational Research Nuclear UniversityCredit: CC0 Public DomainTogether with researchers from the University of Nantes and the University of Reims Champagne-Ardenne in France, experts from the N
Longer wait for some forms of cancer diagnosis for Black and Asian patients

Longer wait for some forms of cancer diagnosis for Black and Asian patients

byUniversity of ExeterSite-specific box and Whisker plots showing ethnic differences in the number of days to diagnosis (lower adjacent value, 25th, 50th, and 75th centiles, and upper adjacent v

Longer wait for some forms of cancer diagnosis for Black and Asian patients

byUniversity of ExeterSite-specific box and Whisker plots showing ethnic differences in the number of days to diagnosis (lower adjacent value, 25th, 50th, and 75th centiles, and upper adjacent v
Novel genetic signature that can predict some kinds of breast cancer is identified

Novel genetic signature that can predict some kinds of breast cancer is identified

by Maria Fernanda Ziegler,FAPESPBlood vessels from the retina of a mouse with retinopathy, normal and pathological vessels stained green and red respectively. Credit: Ricardo GiordanoResearchers

Novel genetic signature that can predict some kinds of breast cancer is identified

by Maria Fernanda Ziegler,FAPESPBlood vessels from the retina of a mouse with retinopathy, normal and pathological vessels stained green and red respectively. Credit: Ricardo GiordanoResearchers
Genetic study provides most comprehensive map of risk to date of breast cancer risk

Genetic study provides most comprehensive map of risk to date of breast cancer risk

byUniversity of CambridgeCredit: CC0 Public DomainA major international study of the genetics of breast cancer has identified more than 350 DNA 'errors' that increase an individual's

Genetic study provides most comprehensive map of risk to date of breast cancer risk

byUniversity of CambridgeCredit: CC0 Public DomainA major international study of the genetics of breast cancer has identified more than 350 DNA 'errors' that increase an individual's
Serotonin-producing neurons regulate malignancy in ependymoma brain tumors

Serotonin-producing neurons regulate malignancy in ependymoma brain tumors

byBaylor College of MedicineStimulation of serotonergic neurons suppresses EPN tumorigenesis. Credit:Nature(2024). DOI: 10.1038/s41586-024-07751-zA study published inNature&nbs

Serotonin-producing neurons regulate malignancy in ependymoma brain tumors

byBaylor College of MedicineStimulation of serotonergic neurons suppresses EPN tumorigenesis. Credit:Nature(2024). DOI: 10.1038/s41586-024-07751-zA study published inNature&nbs